SCHEMBL24310294

SCHEMBL24310294

CONc1cccc(SNc2nc(Oc3ccccc3)cc(-c3ccccc3C)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR39 O43194 1/20 0.38
MAPT P10636 4/20 0.35
MAPK1 P28482 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2C19 P33261 3/20 0.35
TSHR P16473 2/20 0.35
CYP2C9 P11712 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 1/20 0.33
GAA P10253 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309263 0.90 POLB (0.34) TSHRLMNAKDM4EMEN1KMT2A
SCHEMBL24310314 0.87 RORC (0.35) MAPTCYP1A2CYP2C19NPSR1LMNA
SCHEMBL24309777 0.83 LMNA (0.38) GPR39MAPTMAPK1L3MBTL1CYP1A2
SCHEMBL24309770 0.81 LMNA (0.34) MAPK1CYP1A2CYP2C19TSHRLMNA
SCHEMBL24310009 0.79 GPR39 (0.45) GPR39MAPTMAPK1L3MBTL1CYP1A2
SCHEMBL24310579 0.78 RORC (0.35) CYP1A2CYP2C19NPSR1LMNAKDM4E
SCHEMBL24330884 0.78 F10 (0.40) GPR39F2
SCHEMBL24309507 0.77 CYP1A2 (0.35) GPR39MAPTCYP1A2CYP2C19TSHR
SCHEMBL24309252 0.76 RXRA (0.39) MAPTMAPK1TSHRNPSR1LMNA
SCHEMBL24310546 0.75 MAPK1 (0.49) GPR39MAPTMAPK1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed